Personal Products & Services
Compare Stocks
5 / 10Stock Comparison
XWEL vs SKIN vs FWRG vs MNST vs PLNT
Revenue, margins, valuation, and 5-year total return — side by side.
Household & Personal Products
Restaurants
Beverages - Non-Alcoholic
Leisure
XWEL vs SKIN vs FWRG vs MNST vs PLNT — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Personal Products & Services | Household & Personal Products | Restaurants | Beverages - Non-Alcoholic | Leisure |
| Market Cap | $7M | $118M | $737M | $74.29B | $3.52B |
| Revenue (TTM) | $29M | $296M | $1.27B | $8.29B | $1.38B |
| Net Income (TTM) | $-17M | $-6M | $18M | $1.91B | $229M |
| Gross Margin | 22.7% | 64.9% | 35.1% | 55.8% | 54.2% |
| Operating Margin | -32.0% | -3.6% | 2.3% | 29.2% | 29.6% |
| Forward P/E | — | — | 60.7x | 33.7x | 13.0x |
| Total Debt | $12M | $379M | $740M | $0.00 | $443M |
| Cash & Equiv. | $3M | $233M | $21M | $2.09B | $346M |
XWEL vs SKIN vs FWRG vs MNST vs PLNT — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Oct 21 | May 26 | Return |
|---|---|---|---|
| XWELL, Inc. (XWEL) | 100 | 4.8 | -95.2% |
| The Beauty Health C… (SKIN) | 100 | 3.3 | -96.7% |
| First Watch Restaur… (FWRG) | 100 | 55.4 | -44.6% |
| Monster Beverage Co… (MNST) | 100 | 178.8 | +78.8% |
| Planet Fitness, Inc. (PLNT) | 100 | 55.3 | -44.7% |
Price return only. Dividends and distributions are not included.
Quick Verdict: XWEL vs SKIN vs FWRG vs MNST vs PLNT
Each card shows where this stock fits in a portfolio — not just who wins on paper.
XWEL is the #2 pick in this set and the best alternative if income & stability is your priority.
- Dividend streak 1 yrs, beta 0.88, yield 3.8%
- 3.8% yield, 1-year raise streak, vs PLNT's 0.0%, (3 stocks pay no dividend)
- +54.5% vs PLNT's -56.7%
Among these 5 stocks, SKIN doesn't own a clear edge in any measured category.
FWRG ranks third and is worth considering specifically for growth exposure.
- Rev growth 20.3%, EPS growth 3.3%, 3Y rev CAGR 18.7%
- 20.3% revenue growth vs XWEL's -13.8%
MNST carries the broadest edge in this set and is the clearest fit for long-term compounding and sleep-well-at-night.
- 206.3% 10Y total return vs PLNT's 203.6%
- Lower volatility, beta 0.26, current ratio 3.70x
- 23.0% margin vs XWEL's -58.2%
- Beta 0.26 vs SKIN's 2.00
PLNT is the clearest fit if your priority is valuation efficiency and defensive.
- PEG 1.80 vs MNST's 4.21
- Beta 0.31, yield 0.0%, current ratio 2.11x
- Lower P/E (13.0x vs 33.7x), PEG 1.80 vs 4.21
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 20.3% revenue growth vs XWEL's -13.8% | |
| Value | Lower P/E (13.0x vs 33.7x), PEG 1.80 vs 4.21 | |
| Quality / Margins | 23.0% margin vs XWEL's -58.2% | |
| Stability / Safety | Beta 0.26 vs SKIN's 2.00 | |
| Dividends | 3.8% yield, 1-year raise streak, vs PLNT's 0.0%, (3 stocks pay no dividend) | |
| Momentum (1Y) | +54.5% vs PLNT's -56.7% | |
| Efficiency (ROA) | 20.8% ROA vs XWEL's -84.7%, ROIC 33.1% vs -124.8% |
XWEL vs SKIN vs FWRG vs MNST vs PLNT — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
XWEL vs SKIN vs FWRG vs MNST vs PLNT — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
MNST leads in 4 of 6 categories
PLNT leads 1 • XWEL leads 1 • SKIN leads 0 • FWRG leads 0
Explore the data ↓Income & Cash Flow (Last 12 Months)
MNST leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
MNST is the larger business by revenue, generating $8.3B annually — 284.0x XWEL's $29M. MNST is the more profitable business, keeping 23.0% of every revenue dollar as net income compared to XWEL's -58.2%. On growth, PLNT holds the edge at +21.9% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $29M | $296M | $1.3B | $8.3B | $1.4B |
| EBITDAEarnings before interest/tax | -$8M | $9M | $109M | $2.5B | $568M |
| Net IncomeAfter-tax profit | -$17M | -$6M | $18M | $1.9B | $229M |
| Free Cash FlowCash after capex | -$12M | $29M | -$9M | $2.0B | $267M |
| Gross MarginGross profit ÷ Revenue | +22.7% | +64.9% | +35.1% | +55.8% | +54.2% |
| Operating MarginEBIT ÷ Revenue | -32.0% | -3.6% | +2.3% | +29.2% | +29.6% |
| Net MarginNet income ÷ Revenue | -58.2% | -2.0% | +1.4% | +23.0% | +16.5% |
| FCF MarginFCF ÷ Revenue | -40.0% | +9.8% | -0.7% | +23.7% | +19.3% |
| Rev. Growth (YoY)Latest quarter vs prior year | -4.2% | -6.7% | +17.3% | +17.6% | +21.9% |
| EPS Growth (YoY)Latest quarter vs prior year | -105.0% | +38.0% | -2.2% | +64.3% | +30.0% |
Valuation Metrics
PLNT leads this category, winning 3 of 7 comparable metrics.
Valuation Metrics
At 16.8x trailing earnings, PLNT trades at a 57% valuation discount to MNST's 39.2x P/E. Adjusting for growth (PEG ratio), PLNT offers better value at 1.80x vs MNST's 4.89x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $7M | $118M | $737M | $74.3B | $3.5B |
| Enterprise ValueMkt cap + debt − cash | $17M | $264M | $1.5B | $72.2B | $3.6B |
| Trailing P/EPrice ÷ TTM EPS | -0.25x | -5.69x | 38.55x | 39.16x | 16.80x |
| Forward P/EPrice ÷ next-FY EPS est. | — | — | 60.72x | 33.72x | 13.04x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | 4.89x | 1.80x |
| EV / EBITDAEnterprise value multiple | — | 7331.15x | 13.38x | 28.50x | 6.57x |
| Price / SalesMarket cap ÷ Revenue | 0.24x | 0.39x | 0.60x | 8.96x | 2.66x |
| Price / BookPrice ÷ Book value/share | — | 2.02x | 1.20x | 9.06x | — |
| Price / FCFMarket cap ÷ FCF | — | 3.17x | — | 37.79x | 13.82x |
Profitability & Efficiency
MNST leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
MNST delivers a 25.7% return on equity — every $100 of shareholder capital generates $26 in annual profit, vs $-9 for SKIN. FWRG carries lower financial leverage with a 1.18x debt-to-equity ratio, signaling a more conservative balance sheet compared to SKIN's 6.20x. On the Piotroski fundamental quality scale (0–9), PLNT scores 9/9 vs XWEL's 2/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | — | -9.4% | +2.9% | +25.7% | — |
| ROA (TTM)Return on assets | -84.7% | -1.2% | +1.0% | +20.8% | +7.4% |
| ROICReturn on invested capital | -124.8% | -6.8% | +1.9% | +33.1% | +35.2% |
| ROCEReturn on capital employed | -129.5% | -4.5% | +2.3% | +31.9% | +14.2% |
| Piotroski ScoreFundamental quality 0–9 | 2 | 7 | 5 | 7 | 9 |
| Debt / EquityFinancial leverage | — | 6.20x | 1.18x | — | — |
| Net DebtTotal debt minus cash | $10M | $146M | $718M | -$2.1B | $97M |
| Cash & Equiv.Liquid assets | $3M | $233M | $21M | $2.1B | $346M |
| Total DebtShort + long-term debt | $12M | $379M | $740M | $0 | $443M |
| Interest CoverageEBIT ÷ Interest expense | -128.64x | 0.81x | 1.64x | 372.36x | 6.73x |
Total Returns (Dividends Reinvested)
MNST leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in MNST five years ago would be worth $16,649 today (with dividends reinvested), compared to $504 for XWEL. Over the past 12 months, XWEL leads with a +54.5% total return vs PLNT's -56.7%. The 3-year compound annual growth rate (CAGR) favors MNST at 8.8% vs SKIN's -56.4% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +182.2% | -35.0% | -22.3% | -0.2% | -59.9% |
| 1-Year ReturnPast 12 months | +54.5% | -35.9% | -25.3% | +25.4% | -56.7% |
| 3-Year ReturnCumulative with dividends | -75.6% | -91.7% | -28.9% | +28.7% | -38.9% |
| 5-Year ReturnCumulative with dividends | -95.0% | -92.9% | -46.0% | +66.5% | -42.9% |
| 10-Year ReturnCumulative with dividends | -100.0% | -91.6% | -46.0% | +206.3% | +203.6% |
| CAGR (3Y)Annualised 3-year return | -37.5% | -56.4% | -10.7% | +8.8% | -15.1% |
Risk & Volatility
MNST leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
MNST is the less volatile stock with a 0.26 beta — it tends to amplify market swings less than SKIN's 2.00 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. MNST currently trades 86.9% from its 52-week high vs SKIN's 33.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.88x | 2.00x | 1.59x | 0.26x | 0.31x |
| 52-Week HighHighest price in past year | $2.20 | $2.69 | $19.53 | $87.38 | $114.47 |
| 52-Week LowLowest price in past year | $0.26 | $0.76 | $10.10 | $58.09 | $37.03 |
| % of 52W HighCurrent price vs 52-week peak | +57.7% | +33.8% | +61.2% | +86.9% | +38.4% |
| RSI (14)Momentum oscillator 0–100 | 53.4 | 52.1 | 46.5 | 54.5 | 32.8 |
| Avg Volume (50D)Average daily shares traded | 2.3M | 760K | 1.6M | 5.2M | 1.8M |
Analyst Outlook
XWEL leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: SKIN as "Hold", FWRG as "Buy", MNST as "Buy", PLNT as "Buy". Consensus price targets imply 170.8% upside for PLNT (target: $119) vs 12.4% for MNST (target: $85). XWEL is the only dividend payer here at 3.78% yield — a key consideration for income-focused portfolios.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Hold | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | — | $1.30 | $19.00 | $85.38 | $119.17 |
| # AnalystsCovering analysts | — | 13 | 15 | 43 | 26 |
| Dividend YieldAnnual dividend ÷ price | +3.8% | — | — | — | +0.0% |
| Dividend StreakConsecutive years of raises | 1 | — | — | — | 0 |
| Dividend / ShareAnnual DPS | $0.05 | — | — | — | $0.02 |
| Buyback YieldShare repurchases ÷ mkt cap | +25.4% | 0.0% | 0.0% | +0.1% | +14.2% |
MNST leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). PLNT leads in 1 (Valuation Metrics).
XWEL vs SKIN vs FWRG vs MNST vs PLNT: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is XWEL or SKIN or FWRG or MNST or PLNT a better buy right now?
For growth investors, First Watch Restaurant Group, Inc.
(FWRG) is the stronger pick with 20. 3% revenue growth year-over-year, versus -13. 8% for XWELL, Inc. (XWEL). Planet Fitness, Inc. (PLNT) offers the better valuation at 16. 8x trailing P/E (13. 0x forward), making it the more compelling value choice. Analysts rate First Watch Restaurant Group, Inc. (FWRG) a "Buy" — based on 15 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — XWEL or SKIN or FWRG or MNST or PLNT?
On trailing P/E, Planet Fitness, Inc.
(PLNT) is the cheapest at 16. 8x versus Monster Beverage Corporation at 39. 2x. On forward P/E, Planet Fitness, Inc. is actually cheaper at 13. 0x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Planet Fitness, Inc. wins at 1. 80x versus Monster Beverage Corporation's 4. 21x — a reasonable growth-adjusted valuation.
03Which is the better long-term investment — XWEL or SKIN or FWRG or MNST or PLNT?
Over the past 5 years, Monster Beverage Corporation (MNST) delivered a total return of +66.
5%, compared to -95. 0% for XWELL, Inc. (XWEL). Over 10 years, the gap is even starker: MNST returned +206. 3% versus XWEL's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — XWEL or SKIN or FWRG or MNST or PLNT?
By beta (market sensitivity over 5 years), Monster Beverage Corporation (MNST) is the lower-risk stock at 0.
26β versus The Beauty Health Company's 2. 00β — meaning SKIN is approximately 675% more volatile than MNST relative to the S&P 500. On balance sheet safety, First Watch Restaurant Group, Inc. (FWRG) carries a lower debt/equity ratio of 118% versus 6% for The Beauty Health Company — giving it more financial flexibility in a downturn.
05Which is growing faster — XWEL or SKIN or FWRG or MNST or PLNT?
By revenue growth (latest reported year), First Watch Restaurant Group, Inc.
(FWRG) is pulling ahead at 20. 3% versus -13. 8% for XWELL, Inc. (XWEL). On earnings-per-share growth, the picture is similar: The Beauty Health Company grew EPS 55. 6% year-over-year, compared to -38. 8% for XWELL, Inc.. Over a 3-year CAGR, FWRG leads at 18. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — XWEL or SKIN or FWRG or MNST or PLNT?
Monster Beverage Corporation (MNST) is the more profitable company, earning 23.
0% net margin versus -58. 2% for XWELL, Inc. — meaning it keeps 23. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: PLNT leads at 29. 8% versus -32. 0% for XWEL. At the gross margin level — before operating expenses — PLNT leads at 82. 6%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is XWEL or SKIN or FWRG or MNST or PLNT more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Planet Fitness, Inc. (PLNT) is the more undervalued stock at a PEG of 1. 80x versus Monster Beverage Corporation's 4. 21x. Both stocks trade at elevated growth-adjusted valuations, so expected growth needs to materialise. On forward earnings alone, Planet Fitness, Inc. (PLNT) trades at 13. 0x forward P/E versus 60. 7x for First Watch Restaurant Group, Inc. — 47. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for PLNT: 170. 8% to $119. 17.
08Which pays a better dividend — XWEL or SKIN or FWRG or MNST or PLNT?
In this comparison, XWEL (3.
8% yield) pays a dividend. SKIN, FWRG, MNST, PLNT do not pay a meaningful dividend and should not be held primarily for income.
09Is XWEL or SKIN or FWRG or MNST or PLNT better for a retirement portfolio?
For long-horizon retirement investors, Monster Beverage Corporation (MNST) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
26), +206. 3% 10Y return). The Beauty Health Company (SKIN) carries a higher beta of 2. 00 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (MNST: +206. 3%, SKIN: -91. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between XWEL and SKIN and FWRG and MNST and PLNT?
These companies operate in different sectors (XWEL (Consumer Cyclical) and SKIN (Consumer Defensive) and FWRG (Consumer Cyclical) and MNST (Consumer Defensive) and PLNT (Consumer Cyclical)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: XWEL is a small-cap income-oriented stock; SKIN is a small-cap quality compounder stock; FWRG is a small-cap high-growth stock; MNST is a mid-cap quality compounder stock; PLNT is a small-cap deep-value stock. XWEL pays a dividend while SKIN, FWRG, MNST, PLNT do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.